BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

266 related articles for article (PubMed ID: 1478004)

  • 21. Daily salivary anticonvulsant monitoring in patients with intractable epilepsy.
    Herkes GK; Eadie MJ
    Clin Exp Neurol; 1989; 26():141-9. PubMed ID: 2642124
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Clinical utility of free drug monitoring.
    Dasgupta A
    Clin Chem Lab Med; 2002 Oct; 40(10):986-93. PubMed ID: 12476936
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Therapeutic drug monitoring of old and newer anti-epileptic drugs.
    Neels HM; Sierens AC; Naelaerts K; Scharpé SL; Hatfield GM; Lambert WE
    Clin Chem Lab Med; 2004; 42(11):1228-55. PubMed ID: 15576287
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Therapeutic drug monitoring in interstitial fluid: a feasibility study using a comprehensive panel of drugs.
    Kiang TK; Schmitt V; Ensom MH; Chua B; Häfeli UO
    J Pharm Sci; 2012 Dec; 101(12):4642-52. PubMed ID: 22941939
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Development of a population pharmacokinetic model for carbamazepine based on sparse therapeutic monitoring data from pediatric patients with epilepsy.
    Carlsson KC; Hoem NO; Glauser T; Vinks AA
    Clin Ther; 2005 May; 27(5):618-26. PubMed ID: 15978311
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A review of saliva: normal composition, flow, and function.
    Humphrey SP; Williamson RT
    J Prosthet Dent; 2001 Feb; 85(2):162-9. PubMed ID: 11208206
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Monitoring prednisolone and prednisone in saliva: a population pharmacokinetic approach in healthy volunteers.
    Teeninga N; Guan Z; Freijer J; Ruiter AF; Ackermans MT; Kist-van Holthe JE; van Gelder T; Nauta J
    Ther Drug Monit; 2013 Aug; 35(4):485-92. PubMed ID: 23783167
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Evaluation of saliva as an alternative matrix for monitoring plasma Zidovudine, Lamivudine and nevirapine concentrations in Rwanda.
    Gras A; Schneider S; Karasi JC; Ternes AM; Sauvageot N; Karasi-Omes C; Henry AP; Schmit JC; Seguin-Devaux C; Arendt V
    Curr HIV Res; 2011 Jun; 9(4):223-8. PubMed ID: 21671885
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Defensins in saliva and the salivary glands.
    Abiko Y; Nishimura M; Kaku T
    Med Electron Microsc; 2003 Dec; 36(4):247-52. PubMed ID: 16228657
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Caffeine in saliva after peroral intake: early sample collection as a possible source of error.
    Biederbick W; Joseph G; Rump A; Theisohn M; Klaus W
    Ther Drug Monit; 1997 Oct; 19(5):521-4. PubMed ID: 9357094
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Carbamazepine and lamotrigine plasma concentrations in epileptic patients during optimising therapy.
    Krasniqi S; Neziri B; Islami H; Bauer S
    Med Arh; 2010; 64(2):80-3. PubMed ID: 20514770
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Measurement of xenobiotics in saliva: is saliva an attractive alternative matrix? Case studies and analytical perspectives.
    Mullangi R; Agrawal S; Srinivas NR
    Biomed Chromatogr; 2009 Jan; 23(1):3-25. PubMed ID: 18816455
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Saliva: a reliable sample matrix in bioanalytics.
    Gröschl M
    Bioanalysis; 2017 Apr; 9(8):655-668. PubMed ID: 28504570
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Therapeutic drug monitoring of non-anticancer drugs in cancer patients.
    Joerger M; Schellens JH; Beijnen JH
    Methods Find Exp Clin Pharmacol; 2004 Sep; 26(7):531-45. PubMed ID: 15538543
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Validation of the immunological method of kinetic interaction of microparticles in solution (KIMS) for the determination of phenytoin in saliva at the Hospital de Niños de Santísima Trinidad.].
    Minetti A; Ducheins S; Suarez HA; Rivolta S; Gonzalez II
    Rev Fac Cien Med Univ Nac Cordoba; 2023 Jun; 80(2):88-92. PubMed ID: 37402306
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cloud-point extraction for the determination of the free fraction of antiepileptic drugs in blood plasma and saliva.
    Rukhadze MD; Tsagareli SK; Sidamonidze NS; Meyer VR
    Anal Biochem; 2000 Dec; 287(2):279-83. PubMed ID: 11112274
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Saliva versus Plasma Therapeutic Drug Monitoring of Pregabalin in Jordanian Patients.
    Idkaidek N; Hamadi S; El-Assi M; Al-Shalalfeh A; Al-Ghazawi A
    Drug Res (Stuttg); 2018 Oct; 68(10):596-600. PubMed ID: 29684922
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Recommendations for therapeutic monitoring of antidepressants].
    Baumann P; Rougemont M; Corruble E; Hiemke C;
    Rev Med Suisse; 2013 Mar; 9(377):577-86. PubMed ID: 23534245
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Lamotrigine clinical pharmacokinetics.
    Rambeck B; Wolf P
    Clin Pharmacokinet; 1993 Dec; 25(6):433-43. PubMed ID: 8119045
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Usefulness of monitoring free (unbound) concentrations of therapeutic drugs in patient management.
    Dasgupta A
    Clin Chim Acta; 2007 Feb; 377(1-2):1-13. PubMed ID: 17026974
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.